Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

31 mars 2026 16h05 HE | Source: Callan JMB Inc.

Callan JMB Reports Full Year 2025 Financial Results and Provides Business Update

The Company Deepened its Government Relationships at Both State and Federal Levels, Particularly to Support Onshoring Initiatives, While Reinforcing the Strength and Stability of Core Emergency...
31 mars 2026 15h00 HE | Source: Investview, Inc.

Investview, Inc. (“INVU”) Reports Full Year 2025 Financial Results, Operational Highlights, and a Year-End Message from the CEO

Company Adopts Strategic Initiatives Designed to Position Itself for Growth During 2026 Haverford, PA, March 31, 2026 (GLOBE NEWSWIRE) -- Investview, Inc. (OTCQB: INVU) operates a diversified...
30 mars 2026 18h08 HE | Source: Range Impact, Inc.

Range Impact Reports Full Year 2025 Financial Results

CLEVELAND, OHIO, March 30, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to acquiring, reclaiming and repurposing distressed...
19 mars 2026 08h36 HE | Source: Moleculin Biotech, Inc.

Moleculin Reports Full Year 2025 Financial Results and Confirms Highly Anticipated 45-Patient Interim Data Unblinding in Pivotal MIRACLE Trial On Track for Mid-2026

Miracle Trial Preliminary Blinded CRc Rate of 40% in First 30 Patients Suggests Encouraging Early Results in Relapsed/Refractory AML HOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech,...